£90.00
The BPC-157/TB-500 (5/5) blend from Adaptog Peptides combines two of the most widely investigated peptides in tissue-repair and cytoprotection research. Each vial pairs 5mg of BPC-157 with 5mg of TB-500, giving researchers a single reagent for studies that examine the combined or comparative effects of both compounds. Adaptog supplies this blend at consistent purity for reproducible experimental work.
BPC-157 and TB-500 are studied across overlapping research areas including angiogenesis, fibroblast activity, and connective-tissue modelling. Combining them in a single vial allows investigators to streamline protocols when their experimental design calls for parallel exposure. Adaptog Peptides supplies the BPC-157/TB-500 (5/5) blend so laboratories can run efficient, well-controlled studies without managing two separate reconstitutions.
Researchers often buy the BPC-157/TB-500 blend from Adaptog Peptides for tasks such as:
Examining additive or comparative effects on cellular migration and repair pathways
Investigating angiogenic markers in controlled in-vitro models
Studying interactions between cytoprotective and actin-binding mechanisms
Streamlining workflows that require both peptides at fixed ratios
Because both peptides have well-documented research profiles, this blend is a practical reagent for laboratories already familiar with each compound. Adaptog Peptides delivers BPC-157/TB-500 (5/5) as a high-purity laboratory blend intended exclusively for qualified research environments. It serves no clinical, diagnostic, or therapeutic purpose.
For research use only. Not for human consumption.
Discount Applied Successfully!
Your savings have been added to the cart.
